221 125

Cited 0 times in

뇌졸중 이차예방을 위한 항혈소판제의 사용: 2012년 한국 뇌졸중 이차예방 진료지침 부분 개정

Other Titles
 Antiplatelet Therapy for Secondary Stroke Prevention: 2012 Focused Update of Korean Clinical Practice Guidelines for Stroke. 
Authors
 박태환  ;  김민기  ;  오형근  ;  오미선  ;  유경호  ;  홍근식  ;  배희준  ;  권순억  ;  나정호  ;  허지회  ;  오창완  ;  이병철  ;  윤병우 
Citation
 Korean Journal of Stroke (대한뇌졸중학회지), Vol.14(1) : 1-5, 2012 
Journal Title
 Korean Journal of Stroke  (대한뇌졸중학회지) 
ISSN
 1229-4101 
Issue Date
2012
Abstract
Writing Committee of Korean clinical practice guidelines for secondary prevention of stroke has reviewed recent randomized controlled trials of cilostazol published after the first edition of Korean clinical practice guidelines that considered evidences published before June 2007. Two clinical trials and 1 meta-analysis which compared cilostazol directly with aspirin in the prevention of stroke in patients with cerebral infarction or transient ischemic attack (TIA) were identified and included for the current guideline update. Review of findings indicates that cilostazol as compared to aspirin achieved a greater reduction of stroke as well as composite vascular events of stroke, myocardial infarction, and vascular death. For safety, cilostazol was associated with fewer major bleeding events than aspirin. Accordingly, new recommendations for cilostazol are made for prevention of stroke in the setting of noncardioembolic stroke or TIA. Changes in the guidelines necessitated by new evidences will be continuously reflected in future guidelines.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/91350
DOI
10.5853/kjs.2012.14.1.1
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실)
Yonsei Authors
허지회(Heo, Ji Hoe)
사서에게 알리기
  feedback
Files in This Item:
T201205320.pdf Download
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse